COVID-19 Treatment Evusheld Not Authorized

Evusheld authorization paused. Ways people who are immunocompromised can protect themselves

FDA has announced that Evusheld is not currently authorized for use because it is unlikely to offer protection against the COVID-19 variants that are common today. Since December 2021, Evusheld has been an option for people who are moderately or severely immunocompromised and people with a history of severe adverse reaction to a COVID-19 vaccine or its components.

CDC has put together a webpage with information for people who are immunocompromised, detailing ways to protect yourself and what to do if you get sick.

If you’ve already received Evusheld, it’s important to know that you may now have less protection from developing COVID-19 if exposed to the variants circulating today. However, there are many things you can do to increase your protection against COVID-19 including staying updated on vaccines, masking in public spaces, and improving indoor ventilation. In addition, several treatments, including Paxlovid and Veklury are available for COVID-19. Timely treatment can reduce your risk of getting very sick, being hospitalized, or dying as a result of an infection.

This resource from the Administration for Strategic Preparedness and Response addresses questions about the change in authorization for Evusheld, and how people who are immunocompromised can protect themselves including staying updated with vaccines, developing 

In light of the FDA’s announcement, CDC’s Morbidity and Mortality Weekly Report details a variety of strategies that people who are immunocompromised can use to protect themselves from the variants of COVID-19 currently circulating in the United States. 

This entry was posted in COVID News and tagged , , , , , . Bookmark the permalink.

Comments are closed.